Qube Research & Technologies LTD Aclaris Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 509,350 shares of ACRS stock, worth $835,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
509,350
Previous 1,350,820
62.29%
Holding current value
$835,334
Previous $2.07 Million
65.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ACRS
# of Institutions
98Shares Held
87.6MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN14.3MShares$23.4 Million15.31% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$15.8 Million0.02% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$14.6 Million2.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.66MShares$10.9 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.77MShares$7.82 Million0.46% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $109M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...